Biotech Values

[jbog]

With roughly $300M of post-offering cash (#msg-146126877), RVNC now has enough to comfortably cover operating expenses through the expected RT002 launch in 1H20.

It'll be close, probably will do a raise upon approval. There's nothing concrete I can come up with without knowing who's going to sell the product. If they try to go it alone, they'll definitely need another raise to fund a non-productive sales force.

Of course if they partner it's another story. The company seems bloated at this point.